Exergen

Exergen is a founder-led, privately-held medical device company that has established itself as a global leader in non-invasive temperature measurement technology. Its core innovation is the temporal artery thermometer, a product line validated by over 100 clinical studies and protected by more than 100 patents. The company serves a diversified market across consumer, healthcare professional/OEM, and industrial sectors, with products sold in 48 countries and used by top hospitals. Exergen's success is built on a strong scientific foundation, regulatory approvals (FDA, ISO), and a focus on providing accurate, fast, and patient-friendly alternatives to traditional thermometry.

Patented Temporal Artery Thermometry (TAT) platform using infrared scanners and proprietary algorithms to measure core body temperature non-invasively via the forehead's temporal artery.

Exergen competes in distinct segments: in the professional/clinical space against other established medical thermometer brands (e.g., Welch Allyn, Braun) and traditional methods; in the consumer market against numerous low-cost digital, infrared, and smart thermometer manufacturers. Its primary competitive advantage is its extensive clinical research and patent portfolio supporting the accuracy of its temporal artery technology.